Thus, results from this study revealed that treatment with TSF significantly suppressed diabetic kidney injury via mechanisms associated with NF-κB-driven renal inflammation and TGF-β/Smad3-mediated renal fibrosis. Here, TGFB1 is linked to renal fibrosis.